Article Text

other Versions

PDF
Safety of percutaneous endoscopic gastrostomy tube placement in patients with continuous-flow ventricular assist devices
  1. Hesam Keshmiri1,
  2. Tariq Yousuf1,
  3. Rasha Issa1,
  4. Sudha Kurien2,
  5. Roeglio Silva3
  1. 1Department of Cardiology, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA
  2. 2Advocate Christ Medical Center, Oak Lawn, Illinois, USA
  3. 3Department of Gastroenterology, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
  1. Correspondence to Dr Tariq Yousuf, Department of Medicine, Advocate Christ Medical Center, 4440 W. 95th St. Oak Lawn, IL 60453, USA; tmyousuf614{at}gmail.com

Abstract

In this retrospective study, the safety of percutaneous endoscopic gastrostomy (PEG) tube placement was evaluated as maintaining adequate nutritional support for patients with left ventricular assist devices is crucial. Nineteen patients who underwent PEG tube placement were followed for an average of 40 days. Overall, minor complications such as infections, bleeding, and PEG tube malposition occurred in just 19% of patients while the rate of major complications such as perforation was 5%. Further randomized control trials are necessary to validate this assertion that the safety of PEG placement in patients with left ventricular assist devices is similar to that of the general population.

  • Cardiology

Statistics from Altmetric.com

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.